CTLA 4 News and Research

RSS
Researchers explore new immune checkpoint for head and neck cancer

Researchers explore new immune checkpoint for head and neck cancer

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

Low-dose radiation therapy may increase uptake of therapeutic nanoparticles by brain tumors

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

New potential immunotherapy target in pancreatic cancer identified

New potential immunotherapy target in pancreatic cancer identified

Nobel Laureates lecture about immune checkpoint therapy for cancer treatment

Nobel Laureates lecture about immune checkpoint therapy for cancer treatment

Study sheds new light on microtubule binding proteins and microtubule dynamics

Study sheds new light on microtubule binding proteins and microtubule dynamics

Study reveals nature of how T cells protect the brain against harmful viruses

Study reveals nature of how T cells protect the brain against harmful viruses

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

CRI to bestow top honors on three scientists for contributions to cancer immunology and immunotherapy

CRI to bestow top honors on three scientists for contributions to cancer immunology and immunotherapy

Immunotherapy combination shrinks melanoma that has spread to the brain

Immunotherapy combination shrinks melanoma that has spread to the brain

Researchers describe promising strategy to remove melanoma's most powerful defenses

Researchers describe promising strategy to remove melanoma's most powerful defenses

Gene linked to hair loss could be exploited to improve cancer immunotherapy

Gene linked to hair loss could be exploited to improve cancer immunotherapy

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Seeing the Unexpected: Regulatory T Cells and Basophils

Seeing the Unexpected: Regulatory T Cells and Basophils

Study finds distinct exhausted T cells that could have implications for fighting different diseases

Study finds distinct exhausted T cells that could have implications for fighting different diseases

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

Cancer Center at BIDMC announces launch of new Immunotherapy Institute